LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

businesswire

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – NEWSnet – News… as it used to be

More Press Releases

June 20, 2026

Neurosurgeon Launches $1,000 Scholarship to Support Future Healthcare Leaders

June 20, 2026

10 Best Construction Companies in Dulwich (2026)

June 20, 2026

Veteran Entrepreneur and Startup Mentor Vijay Talreja Launches Before You Become a Founder

June 20, 2026

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

Neurosurgeon Launches $1,000 Scholarship to Support Future Healthcare Leaders

10 Best Construction Companies in Dulwich (2026)

Veteran Entrepreneur and Startup Mentor Vijay Talreja Launches Before You Become a Founder

ClearDiagnosis Launches AI-Powered Medical Second Opinions, Reviewed by Licensed Physicians